Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2025 08:00 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

Prioritizing VTP-1000 development in celiac disease, Phase 1 data expected in mid-2025Postponing further clinical development of VTP-300 in chronic hepatitis B (CHB) until a partner is...
June 12, 2024 16:01 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
January 05, 2024 16:01 ET | Source: Barinthus Biotherapeutics

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones